Compare FLNC & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FLNC | NVCR |
|---|---|---|
| Founded | 2018 | 2000 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 1.5B |
| IPO Year | 2021 | 2015 |
| Metric | FLNC | NVCR |
|---|---|---|
| Price | $13.77 | $10.91 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 18 | 6 |
| Target Price | $16.93 | ★ $28.08 |
| AVG Volume (30 Days) | ★ 3.5M | 1.2M |
| Earning Date | 05-06-2026 | 04-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 21.79 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,262,830,000.00 | $655,353,000.00 |
| Revenue This Year | $51.18 | $7.72 |
| Revenue Next Year | $21.37 | $6.74 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 8.28 |
| 52 Week Low | $3.46 | $9.82 |
| 52 Week High | $33.51 | $20.05 |
| Indicator | FLNC | NVCR |
|---|---|---|
| Relative Strength Index (RSI) | 36.55 | 40.06 |
| Support Level | $7.02 | N/A |
| Resistance Level | $18.21 | $13.59 |
| Average True Range (ATR) | 0.99 | 0.58 |
| MACD | -0.06 | -0.18 |
| Stochastic Oscillator | 19.14 | 23.02 |
Fluence Energy Inc provides intelligent energy storage and optimization software for renewables and storage. Its energy storage solutions and operational services support a more resilient grid and help unlock the potential of renewable portfolios. The company's offerings include energy storage solutions, recurring operational and maintenance services, and Software-as-a-Service (SaaS) products designed to meet customer business needs, performance requirements, in-house capabilities, and risk profiles. Its service plans offer varying levels of training, maintenance, guarantees, warranties, and support for active system management. The company operates in the Americas, APAC and EMEA, with the majority of revenue coming from the Americas.
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.